Literature DB >> 34888834

Astroglia and Obsessive Compulsive Disorder.

Kohichi Tanaka1.   

Abstract

Obsessive compulsive disorder (OCD) has a prevalence rate of 1-3% in the general population and has been ranked as one of the top ten leading causes of illness-related disability (American Psychiatric Association 2013; Kessler et al. 2005). OCD is characterized by persistent intrusive thoughts (obsessions) and repetitive behaviors (compulsions) (Leckman et al. 1997). There are various OCD-related disorders, including Tourette syndrome (TS), grooming disorders (e.g., skin-picking, trichotillomania), and autism spectrum disorders (ASD) that share considerable overlapping features with OCD (Browne et al. 2014). Although the neurobiological basis of OCD still remains obscure, neuroimaging studies in patients with OCD and OCD-related disorders have consistently identified hyperactivity in orbitofrontal cortex and striatum (Cerliani et al. 2015; Hou et al. 2014; Jung et al. 2017; Neuner et al. 2014). However, the cellular and synaptic abnormalities underlying this hyperactivity are unclear. The most prominent theory regarding the underlying mechanisms of OCD and OCD-related disorders is an increased excitation to inhibition (E/I) ratio due to increased glutamatergic excitation or reduced GABAergic inhibition (Albin and Mink 2006; Rubenstein and Merzenich 2003; Wu et al. 2012). A proper E/I ratio is achieved by factors expressed in neuron and glia. In astrocytes, both the glutamate transporter GLT1 and GABA transporter GAT-3 are critical for regulating the E/I balance (Aida et al. 2015; Aizawa et al. 2020; Boddum et al. 2016; Cui et al. 2014; Kersanté et al. 2013; Kiryk et al. 2008; Matos et al. 2018; Scimemi 2014; Sugimoto et al. 2018; Sugiyama et al. 2017; Tanaka et al. 1997; Zhao et al. 2018). Although astrocyte dysfunction has not been directly explored in OCD patients, several animal studies have found that astrocytes are involved in the pathophysiology of OCD. In this chapter, I highlight recent studies in which astrocyte dysfunction contributed to E/I imbalance, leading to pathological repetitive behaviors shared between patients with OCD, TS, and ASD.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Mesh:

Year:  2021        PMID: 34888834     DOI: 10.1007/978-3-030-77375-5_7

Source DB:  PubMed          Journal:  Adv Neurobiol


  53 in total

Review 1.  Astrocyte calcium signaling: the third wave.

Authors:  Narges Bazargani; David Attwell
Journal:  Nat Neurosci       Date:  2016-02       Impact factor: 24.884

2.  Increased Metabotropic Glutamate Receptor 5 Signaling Underlies Obsessive-Compulsive Disorder-like Behavioral and Striatal Circuit Abnormalities in Mice.

Authors:  Kristen K Ade; Yehong Wan; Harold C Hamann; Justin K O'Hare; Weirui Guo; Anna Quian; Sunil Kumar; Srishti Bhagat; Ramona M Rodriguiz; William C Wetsel; P Jeffrey Conn; Kafui Dzirasa; Kimberly M Huber; Nicole Calakos
Journal:  Biol Psychiatry       Date:  2016-05-13       Impact factor: 13.382

Review 3.  Recent advances in Tourette syndrome research.

Authors:  Roger L Albin; Jonathan W Mink
Journal:  Trends Neurosci       Date:  2006-01-23       Impact factor: 13.837

4.  Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder.

Authors:  Paul Daniel Arnold; Tricia Sicard; Eliza Burroughs; Margaret A Richter; James L Kennedy
Journal:  Arch Gen Psychiatry       Date:  2006-07

5.  Diffusion functional MRI reveals global brain network functional abnormalities driven by targeted local activity in a neuropsychiatric disease mouse model.

Authors:  Yoshifumi Abe; Norio Takata; Yuki Sakai; Hiro Taiyo Hamada; Yuichi Hiraoka; Tomomi Aida; Kohichi Tanaka; Denis Le Bihan; Kenji Doya; Kenji F Tanaka
Journal:  Neuroimage       Date:  2020-09-01       Impact factor: 6.556

6.  Repeated cortico-striatal stimulation generates persistent OCD-like behavior.

Authors:  Susanne E Ahmari; Timothy Spellman; Neria L Douglass; Mazen A Kheirbek; H Blair Simpson; Karl Deisseroth; Joshua A Gordon; René Hen
Journal:  Science       Date:  2013-06-07       Impact factor: 47.728

7.  Glial glutamate transporter GLT-1 determines susceptibility to spreading depression in the mouse cerebral cortex.

Authors:  Hidenori Aizawa; Weinan Sun; Kaori Sugiyama; Yukiko Itou; Tomomi Aida; Wanpeng Cui; Saori Toyoda; Haruhi Terai; Michiko Yanagisawa; Kohichi Tanaka
Journal:  Glia       Date:  2020-06-25       Impact factor: 7.452

8.  Astroglial glutamate transporter deficiency increases synaptic excitability and leads to pathological repetitive behaviors in mice.

Authors:  Tomomi Aida; Junichi Yoshida; Masatoshi Nomura; Asami Tanimura; Yusuke Iino; Miho Soma; Ning Bai; Yukiko Ito; Wanpeng Cui; Hidenori Aizawa; Michiko Yanagisawa; Terumi Nagai; Norio Takata; Kenji F Tanaka; Ryoichi Takayanagi; Masanobu Kano; Magdalena Götz; Hajime Hirase; Kohichi Tanaka
Journal:  Neuropsychopharmacology       Date:  2015-02-09       Impact factor: 7.853

9.  Astrocytic GABA transporter activity modulates excitatory neurotransmission.

Authors:  Kim Boddum; Thomas P Jensen; Vincent Magloire; Uffe Kristiansen; Dmitri A Rusakov; Ivan Pavlov; Matthew C Walker
Journal:  Nat Commun       Date:  2016-11-25       Impact factor: 14.919

10.  Water diffusion closely reveals neural activity status in rat brain loci affected by anesthesia.

Authors:  Yoshifumi Abe; Tomokazu Tsurugizawa; Denis Le Bihan
Journal:  PLoS Biol       Date:  2017-04-13       Impact factor: 8.029

View more
  3 in total

Review 1.  Astrocyte regulation of synaptic signaling in psychiatric disorders.

Authors:  Anna Kruyer; Peter W Kalivas; Michael D Scofield
Journal:  Neuropsychopharmacology       Date:  2022-05-16       Impact factor: 7.853

Review 2.  The Potential of N-Acetylcysteine for Treatment of Trichotillomania, Excoriation Disorder, Onychophagia, and Onychotillomania: An Updated Literature Review.

Authors:  Debra K Lee; Shari R Lipner
Journal:  Int J Environ Res Public Health       Date:  2022-05-24       Impact factor: 4.614

Review 3.  Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases.

Authors:  Thomas McGrath; Richard Baskerville; Marcelo Rogero; Linda Castell
Journal:  Nutrients       Date:  2022-02-22       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.